List of works - Sanjay Popat

193TiP: CheckMate 171: A multicenter phase 2 trial of nivolumab (nivo) in patients (pts) with stage IIIB/IV squamous cell (SQ) NSCLC who have received ≥1 prior systemic treatment

A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer

scientific article published on 28 April 2016

A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material.

scientific article

A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.

scientific article published on 26 December 2015

A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12weeks ⬇️

scientific article published on November 24, 2011

A pilot study of a novel home telemonitoring system for oncology patients receiving chemotherapy.

scientific article published on 24 April 2013

A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings

scientific article

A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer

article

A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic

scientific article published on 10 November 2015

A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma

scientific article published on 5 May 2016

A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations.

scientific article published on 15 March 2013

A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice

scientific article

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

scientific article published on 5 October 2017

A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis

scientific article

AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines

scientific article

ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma.

scientific article

Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.

scientific article published on 14 March 2017

Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer.

scientific article

Afatinib in the treatment of EGFR mutation-positive NSCLC--a network meta-analysis.

scientific article

Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: the United Kingdom Named Patient Programme.

scientific article published on 10 April 2014

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

scientific article

Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer.

scientific article published on 28 August 2015

Allelic imbalance in colorectal cancer at the CRAC1 locus in early-onset colorectal cancer

scientific article published on 01 August 2003

An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach.

scientific article published on 8 June 2017

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity.

scientific article

Analysis of the CTLA4 gene in Swedish coeliac disease patients

article

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

scientific article

Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies

scientific article published on 22 June 2016

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss ⬇️

scientific article

Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural Effusions.

scientific article

Chemotherapy strategies in the treatment of small cell lung cancer.

scientific article

Chemotherapy-induced bowel obstruction in small cell lung cancer: a case report

scientific article published on 28 December 2011

Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit.

scientific article published on 16 February 2017

Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases.

scientific article published on 17 December 2015

Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLC

scientific article

Continuing EGFR inhibition beyond progression in advanced non-small cell lung cancer.

scientific article published on 17 November 2016

Crizotinib for ROS1 patients: One small step in biomarker testing, one giant leap for advanced NSCLC patients

scientific article published on 11 November 2016

Development of molecularly targeted agents and immunotherapies in small cell lung cancer.

scientific article published on 6 April 2016

Do Statins Improve Survival in Small-Cell Lung Cancer?

scientific article published on 06 March 2017

EGFR Exon 20 Insertion (A763_Y764insFQEA) Mutant NSCLC Is Not Identified by Roche Cobas Version 2 Tissue Testing but Has Durable Intracranial and Extracranial Response to Osimertinib

scientific article published on 01 October 2020

EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer.

scientific article

Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma

scientific article

Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival

scientific article published on 01 August 2007

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach

scientific article published on 28 September 2015

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

scientific article published on 10 April 2017

Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer.

scientific article published on 24 October 2007

Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors

scientific article published on 27 October 2011

Eventual role of EGFR-tyrosine kinase inhibitors in early-stage non-small-cell lung cancer.

scientific article published on February 2016

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations ⬇️

scientific article published on October 14, 2011

Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome

scientific article published on February 2005

First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases.

scientific article published on 20 January 2016

First-line Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors for EGFR Mutant Non-small Cell Lung Cancer: And the Winner is….

scientific article

Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice

scientific article published on 18 November 2015

Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence

scientific article (publication date: November 2006)

Genome screening of coeliac disease.

scientific article published in May 2002

Good vibrations and the power of positron thinking: positron emission tomography and endoscopic ultrasound in staging of mesothelioma-two case reports.

scientific article published in May 2008

Guidelines on the radical management of patients with lung cancer

scientific article published on 01 October 2010

Gut microflora associated characteristics in first-degree relatives of children with celiac disease

scientific article published on October 2007

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

scientific article published on 13 May 2016

Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010.

scientific article published on 3 August 2011

Hyperprogression with immunotherapy: Is it real?

scientific article published on 15 February 2019

In Reply:

Influence of co-morbidity on renal function assessment by Cockcroft-Gault calculation in lung cancer and mesothelioma patients receiving platinum-based chemotherapy.

scientific article published on 21 February 2011

Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance

scientific article published on 5 June 2006

LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma

scientific article

Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia

scientific article published on 01 October 1999

Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib

scientific article published on 01 November 2011

Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064).

scientific article published on 11 June 2015

Malignant pleural mesothelioma: two cases in first degree relatives.

scientific article

Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer.

scientific article published on 09 June 2017

Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer.

scientific article published on 23 March 2016

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article

Mismatch repair, minichromosome maintenance complex component 2, cyclin A, and transforming growth factor β receptor type II as prognostic factors for colorectal cancer: results of a 10-year prospective study using tissue microarray analysis.

scientific article

Molecular Adequacy of Image-Guided Rebiopsies for Molecular Retesting in Advanced Non-Small Cell Lung Cancer: A Single-Center Experience

scientific article published on 5 October 2017

Mutational analysis of CD28 in coeliac disease.

scientific article

Navigating diagnostic and treatment decisions in non-small-cell lung cancer: expert commentary on the multidisciplinary team approach

scientific article published on 03 November 2020

Never smoker with ground glass opacities on CT

scientific article published on 01 April 2015

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial.

scientific article published on 11 September 2017

Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer of adenocarcinoma histology: a network meta-analysis vs new therapeutic options

scientific article published on 27 February 2017

Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis

scientific article

Novel insights into mesothelioma biology and implications for therapy.

scientific article

Osimertinib as First-Line Treatment in EGFR-Mutated Non-Small-Cell Lung Cancer.

scientific article published in January 2018

Palliative treatments for patients with inoperable gastroesophageal cancers

scientific article

Patient factors, health care factors and survival from lung cancer according to ethnic group in the south of London, UK.

scientific article

Patient reported outcomes from LUX-Lung 3: first-line afatinib is superior to chemotherapy-would patients agree?

scientific article published on January 2014

Patterns of relapse in extrapulmonary small cell carcinoma: retrospective analysis of outcomes from two cancer centres

scientific article

Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapy.

scientific article published in June 2013

Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?

scientific article published on 15 June 2017

Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Trea

scientific article

Platinum-based chemotherapy in triple-negative breast cancer.

scientific article

Polymorphic sequence variants in medicine: a challenge and an opportunity.

scientific article

Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer.

scientific article

Prevalence of the APC E1317Q variant in colorectal cancer patients

scientific article published on 01 February 2000

Problems of variable biomarker evaluation in stratified medicine research--A case study of ERCC1 in non-small-cell lung cancer

scientific article

Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer

scientific article published in January 2014

Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer

scientific article published on 13 November 2014

Rationale for targeting the ErbB family of receptors in patients with advanced squamous cell carcinoma of the lung.

scientific article published on 18 May 2015

Re: Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

scientific article published on 01 June 2005

Re: Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

scientific article published on 01 December 2005

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

scientific article published in April 2010

Relationship between chromosome 18q status and colorectal cancer prognosis: a prospective, blinded analysis of 280 patients

scientific article published on 01 January 2007

Relationship between thymidylate synthase (TS) genotype and TS expression: a tissue microarray analysis of colorectal cancers

scientific article published in April 2005

Resolution of severe hyponatraemia is associated with improved survival in patients with cancer

scientific article

Response evaluation in mesothelioma: Beyond RECIST.

scientific article published on 22 August 2015

Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene

scientific article

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data

scientific article

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

scientific article

Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061).

scientific article

Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

scientific article published on September 2010

Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy

scientific article published on 23 June 2017

Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients ⬇️

scientific article published on April 12, 2013

Systematic review of microsatellite instability and colorectal cancer prognosis

scientific article

Systemic therapy for pulmonary carcinoids.

scientific article published on 11 September 2015

Tailoring Microbial Electrochemical Cells for Production of Hydrogen Peroxide at High Concentrations and Efficiencies.

scientific article published on 10 November 2016

Targeting MET Exon 14 Skipping Alterations: Has Lung Cancer MET Its Match?

scientific article

The National Lung Matrix Trial of personalized therapy in lung cancer

scientific article published on 15 July 2020

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer

scientific article

The combination of Young's syndrome and small cell lung cancer-A spiky connection?

scientific article published in December 2009

The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer.

scientific article published on 22 March 2015

The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer.

scientific article published on September 2010

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis

scientific article published on February 2004

Time and chemotherapy treatment trends in the treatment of elderly patients (age >/=70 years) with small cell lung cancer.

scientific article published on January 2006

Time and chemotherapy treatment trends in the treatment of elderly patients (age>or=70 years) with non-small cell lung cancer

scientific article published on 01 March 2008

Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer.

scientific article

Transformation to "high grade" neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma.

scientific article

Transformation to neuroendocrine carcinoma as a resistance mechanism to lorlatinib

scientific article published on 06 June 2019

Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications.

scientific article published on 30 January 2017

Treatment options for small cell lung cancer - do we have more choice?

scientific article

Treatments for EGFR Mutation-Positive (M+) NSCLC Patients - A Network Meta-Analysis (NMA) by Mutation Type

scientific article published on 26 October 2014

True hypoglycaemia secondary to treatment with granulocyte colony stimulating factor (G-CSF) in a diabetic patient with non-small cell lung cancer

scientific article published on 27 November 2011

Under usage of zoledronic acid in non-small cell lung cancer patients with metastatic bone disease – a short communication ⬇️

scientific article published on June 16, 2011

Watch the weathercock: changes in re-staging 18F-FDG PET/CT scan predict the probability of relapse in locally advanced non-small cell lung cancer.

scientific article published on 24 July 2015

What exactly are we doing to improve low lung cancer survival in the United Kingdom?

scientific article published on 10 April 2013

List of works by Sanjay Popat

193TiP: CheckMate 171: A multicenter phase 2 trial of nivolumab (nivo) in patients (pts) with stage IIIB/IV squamous cell (SQ) NSCLC who have received ≥1 prior systemic treatment

A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer

A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material.

A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.

A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12weeks ⬇️

A pilot study of a novel home telemonitoring system for oncology patients receiving chemotherapy.

A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings

A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer

A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic

A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma

A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations.

A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis

AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines

ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma.

Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.

Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer.

Afatinib in the treatment of EGFR mutation-positive NSCLC--a network meta-analysis.

Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: the United Kingdom Named Patient Programme.

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer.

Allelic imbalance in colorectal cancer at the CRAC1 locus in early-onset colorectal cancer

An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach.

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity.

Analysis of the CTLA4 gene in Swedish coeliac disease patients

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss ⬇️

Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural Effusions.

Chemotherapy strategies in the treatment of small cell lung cancer.

Chemotherapy-induced bowel obstruction in small cell lung cancer: a case report

Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit.

Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases.

Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLC

Continuing EGFR inhibition beyond progression in advanced non-small cell lung cancer.

Crizotinib for ROS1 patients: One small step in biomarker testing, one giant leap for advanced NSCLC patients

Development of molecularly targeted agents and immunotherapies in small cell lung cancer.

Do Statins Improve Survival in Small-Cell Lung Cancer?

EGFR Exon 20 Insertion (A763_Y764insFQEA) Mutant NSCLC Is Not Identified by Roche Cobas Version 2 Tissue Testing but Has Durable Intracranial and Extracranial Response to Osimertinib

EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer.

Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma

Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer.

Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors

Eventual role of EGFR-tyrosine kinase inhibitors in early-stage non-small-cell lung cancer.

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations ⬇️

Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome

First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases.

First-line Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors for EGFR Mutant Non-small Cell Lung Cancer: And the Winner is….

Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice

Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence

Genome screening of coeliac disease.

Good vibrations and the power of positron thinking: positron emission tomography and endoscopic ultrasound in staging of mesothelioma-two case reports.

Guidelines on the radical management of patients with lung cancer

Gut microflora associated characteristics in first-degree relatives of children with celiac disease

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010.

Hyperprogression with immunotherapy: Is it real?

In Reply:

Influence of co-morbidity on renal function assessment by Cockcroft-Gault calculation in lung cancer and mesothelioma patients receiving platinum-based chemotherapy.

Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance

LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma

Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia

Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib

Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064).

Malignant pleural mesothelioma: two cases in first degree relatives.

Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer.

Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer.

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Mismatch repair, minichromosome maintenance complex component 2, cyclin A, and transforming growth factor β receptor type II as prognostic factors for colorectal cancer: results of a 10-year prospective study using tissue microarray analysis.

Molecular Adequacy of Image-Guided Rebiopsies for Molecular Retesting in Advanced Non-Small Cell Lung Cancer: A Single-Center Experience

Mutational analysis of CD28 in coeliac disease.

Navigating diagnostic and treatment decisions in non-small-cell lung cancer: expert commentary on the multidisciplinary team approach

Never smoker with ground glass opacities on CT

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial.

Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer of adenocarcinoma histology: a network meta-analysis vs new therapeutic options